141 related articles for article (PubMed ID: 19419505)
1. Six principal symptoms and coronary artery sequelae in Kawasaki disease.
Nakamura Y; Yashiro M; Sadakane A; Aoyama Y; Oki I; Uehara R; Yanagawa H
Pediatr Int; 2009 Oct; 51(5):705-8. PubMed ID: 19419505
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
[TBL] [Abstract][Full Text] [Related]
3. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Sonobe T; Yanagawa H
Pediatr Int; 2004 Feb; 46(1):33-8. PubMed ID: 15043662
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
[TBL] [Abstract][Full Text] [Related]
6. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
Okubo Y; Nochioka K; Sakakibara H; Testa M; Sundel RP
Clin Rheumatol; 2017 Feb; 36(2):413-419. PubMed ID: 27987089
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of giant coronary aneurysms due to Kawasaki disease.
Nakamura Y; Yashiro M; Uehara R; Watanabe M; Tajimi M; Oki I; Ojima T; Yanagawa H
Pediatr Int; 2003 Aug; 45(4):410-3. PubMed ID: 12911476
[TBL] [Abstract][Full Text] [Related]
8. Factors related to cardiac sequelae of Kawasaki disease.
Zhang T; Yanagawa H; Oki I; Nakamura Y; Yashiro M; Ojima T; Tanihara S
Eur J Pediatr; 1999 Sep; 158(9):694-7. PubMed ID: 10485297
[TBL] [Abstract][Full Text] [Related]
9. Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan.
Kuwabara M; Yashiro M; Kotani K; Tsuboi S; Ae R; Nakamura Y; Yanagawa H; Kawasaki T
J Epidemiol; 2015; 25(3):189-93. PubMed ID: 25716055
[TBL] [Abstract][Full Text] [Related]
10. Physical and psychosocial health in children who have had Kawasaki disease.
Baker AL; Gauvreau K; Newburger JW; Sundel RP; Fulton DR; Jenkins KJ
Pediatrics; 2003 Mar; 111(3):579-83. PubMed ID: 12612239
[TBL] [Abstract][Full Text] [Related]
11. Giant coronary aneurysms due to Kawasaki disease: a case-control study.
Nakamura Y; Yashiro M; Oki I; Tanihara S; Ojima T; Yanagawa H
Pediatr Int; 2002 Jun; 44(3):254-8. PubMed ID: 11982891
[TBL] [Abstract][Full Text] [Related]
12. Predictors of coronary artery aneurysms in Kawasaki disease.
Ram Krishna M; Sundaram B; Dhanalakshmi K
Clin Pediatr (Phila); 2014 Jun; 53(6):561-5. PubMed ID: 24817593
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease patients with six principal symptoms have a high risk of being a non-responder.
Nomura Y; Arata M; Masuda K; Koriyama C; Suruki N; Ueno K; Yoshikawa H; Eguchi T; Kawano Y
Pediatr Int; 2012 Feb; 54(1):14-8. PubMed ID: 22115193
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.
Liu AM; Ghazizadeh M; Onouchi Z; Asano G
Microvasc Res; 1999 Jul; 58(1):10-27. PubMed ID: 10388599
[TBL] [Abstract][Full Text] [Related]
15. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
Michihata N; Matsui H; Fushimi K; Yasunaga H
Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study.
Berdej-Szczot E; Firek-Pędras M; Szydłowski L; Krzystolik-Ładzińska J; Klimek K; Małecka-Tendera E
Kardiol Pol; 2013; 71(12):1279-86. PubMed ID: 23990228
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease.
Honkanen VE; McCrindle BW; Laxer RM; Feldman BM; Schneider R; Silverman ED
Pediatr Cardiol; 2003; 24(2):122-6. PubMed ID: 12457252
[TBL] [Abstract][Full Text] [Related]
18. [Kawasaki disease: heart disease during childhood].
Schroh AM; Domínguez P; Laghezza LB; Melonari PA; Olguín M; Miatello R
Rev Esp Cardiol; 2006 Apr; 59(4):387-90. PubMed ID: 16709393
[TBL] [Abstract][Full Text] [Related]
19. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease.
Koyanagi H; Nakamura Y; Yanagawa H
Acta Paediatr; 1998 Jan; 87(1):32-6. PubMed ID: 9510444
[TBL] [Abstract][Full Text] [Related]
20. Nationwide survey of coronary aneurysms with diameter >6 mm in Kawasaki disease in Korea.
Jang GY; Kang IS; Choi JY; Bae EJ; Kim YH; Kim SH; Ma JS
Pediatr Int; 2015 Jun; 57(3):367-72. PubMed ID: 25406095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
